Am J Transplant, Volume 20, Suppl 3 Archives - Page 210 of 223 - ATC Abstracts

2020 American Transplant Congress
MELD is MELD is MELD? Geographic/ Center-Level Variation in Mortality for Patients with the Same MELD Score
T. Ishaque¹, A. B. Massie¹, A. B. Kernodle¹, S. Getsin¹, P. Chaing¹, J. G. Jacqueline Garonzik Wang¹, S. Gentry², D. Segev¹
¹Johns Hopkins University, Baltimore, MD, ²Department of Mathematics, United States Naval Academy, Annapolis, MD
*Purpose: Waitlist candidates living in areas with poor access to health care may have higher mortality risk compared to candidates with same MELD in other…
2020 American Transplant Congress
The Efficacy and Safety of Ischemia-Free Liver Transplantation (IFLT) in the Treatment of End-Stage Liver Disease in a Prospective, Randomized, Controlled Trial: A Report of the First 25 Cases
X. He, Z. Guo, Q. Zhao, C. Huang, W. Ju, D. Wang, M. Chen, L. Wu, Y. Ma, Y. Chen, A. Hu, X. Zhu
Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China
*Purpose: We’ve established a novel procedure called ischemia-free liver transplantation (IFLT). The results from the pilot study suggest that IFLT might prevent ischemia-reperfusion injury (IRI)…
2020 American Transplant Congress
CD11b is a Novel Alternate Receptor for CD154 During Alloimmunity
M. L. Ford, D. Liu
Emory University, Atlanta, GA
*Purpose: For decades, blockade of CD40-CD154 has been shown to be a highly effective means of inhibiting alloreactive T cell responses and inducing long-term graft…
2020 American Transplant Congress
Eosinophils Maintain Lung Allograft Tolerance by Sequestering CD8+ T Cells in Bronchial Associated Lymphoid Tissue
Z. Mei¹, Y. Guo¹, A. Hata¹, A. Banerjee¹, D. Li¹, A. Manafi¹, B. Mahgoub¹, D. Kreisel², A. Gelman², A. S. Krupnick¹
¹Department of Surgery, University of Virginia, Charlottesville, VA, ²Department of Surgery, Washington University in St. Louis, St. Louis, MO
*Purpose: It has been recently described that eosinophils can facilitate immunosuppression-mediated acceptance of murine lung allografts. But the role of eosinophils in long term maintenance…
2020 American Transplant Congress
Single Dose Rituximab and Anti-Thymocyte Globulin (ATG) Induction in Hypersensitized Kidney Transplant Recipients
A. X. Wang, U. Wang, S. Busque, C. R. Lenihan
Stanford University School of Medicine, Stanford, CA
*Purpose: Hypersensitized kidney transplant recipients (calculated panel reactive antibody (cPRA) ≥98%) may represent a population at high risk of posttransplant immunologic events. While access to…
2020 American Transplant Congress
Incidence of Antibody Mediated Rejection in Living Kidney Transplant Recipients with Sensitizing History
Y. Kakuta¹, M. Okumi¹, T. Kanzawa¹, K. Unagami², H. Ishida², K. Tanabe¹
¹Urology, Tokyo Women's Medical University, Tokyo, Japan, ²Organ Transplant Regulation, Tokyo Women's Medical University, Tokyo, Japan
*Purpose: A donor-reactive alloimmune memory response can arise from prior exposure to foreign human leukocyte antigen by sensitization history in transplant recipients. Assessing risk levels…
2020 American Transplant Congress
Deep Learning for Living Donor Surgery: AI Recognition of Surgical Video to Develop Navigation Systems for Laparoscopic Nephrectomy
M. Nishihara¹, K. Iwadoh², M. Noriyuki¹, I. Koyama², I. Nakajima², M. Tonsho¹
¹Transplant Surgery, International University of Health and Welfare, Mita Hospital, Tokyo, Japan, ²Kidney Surgery, Tokyo Women's Medical University Hospital, Tokyo, Japan
*Purpose: Laparoscopic surgery for living donors requires high safety, thus establishing of navigation system for surgical operation is urged. The purpose of this study was…
2020 American Transplant Congress
Transplantation of HCV Positive Kidneys Confers Excellent Outcomes for HCV Infected and Uninfected Recipients
J. Torabi, N. Muhdi, A. Montal, J. Melvin, Y. Miura, J. P. Rocca, M. Ajaimy, L. Lirano, Y. Azzi, C. Pynadath, O. Alani, E. Akalin, S. Greenstein, M. Kinkhabwala, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: Hepatitis C positive (HCV+) donor kidneys were previously transplanted only into HCV infected recipients (D+/R+). Availability of direct acting anti-virals (DAA) has facilitated the…
2020 American Transplant Congress
Acute Rejection in the First Year is a Risk Factor for Subsequent Cardiac Events in Kidney Transplant Recipients
F. Aziz, R. Tao, S. Parajuli, N. Garg, D. Mandelbrot, B. Astor, A. Djamali
University of Wisconsin, Madison, WI
*Purpose: Cardiac events (CE) remain an important cause of morbidity and mortality after the first post-transplant year. We sought to determine whether acute rejection in…
2020 American Transplant Congress
Outcome of Large Donor-Recipient Age Gap in Live-Donor Renal Transplant in Tacrolimus Era
K. Soliman¹, T. Fulop¹, M. Mohamed Ahmed¹, A. Osman², A. Posadas¹, M. Casey¹, V. Rao¹, V. Rohan³, D. Dubay³, S. Nadig³, H. Ali⁴
¹Medicine, Medical University of South Carolina, Charleston, SC, ²Medicine, Cairo University, Cairo, Egypt, ³Surgery, Medical University of South Carolina, Charleston, SC, ⁴Medicine, Royal Stoke University, Royal Stoke, United Kingdom
*Purpose: A large donor-to-recipient age gap among deceased-donor renal transplant (RT) patients leads to worse outcomes. However, the impact of this age gap among live-donor…